Artificial Intelligence In Life Sciences Market Trends And Growth Outlook Across The 2026–2030 Forecast Period
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Size Of The Artificial Intelligence In Life Sciences Market Progress Through 2030?
The artificial intelligence in life sciences market size has experienced significant expansion in recent years. It is anticipated to increase from $3.59 billion in 2025 to $4.44 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 23.6%. The historical growth of this market can be attributed to the increasing complexity of biological datasets, the expansion of genomics research, the rising adoption of digital lab technologies, the early integration of AI in biotechnology research, and the growing demand for faster research cycles.
The artificial intelligence in life sciences market size is set to experience significant expansion in the upcoming years. It is anticipated to grow to $10.43 billion by 2030, achieving a compound annual growth rate (CAGR) of 23.8%. This expected growth during the forecast period can be attributed to increased investments in personalized medicine, the rising deployment of AI-enabled laboratory automation, the expansion of cloud-based life science platforms, growing collaboration between tech and life science firms, and increasing regulatory acceptance of AI-driven insights. Major trends for the forecast period include the increasing integration of AI across life science workflows, a rising adoption of AI-driven data analytics platforms, the growing use of automation in laboratory operations, the expansion of AI-based precision medicine applications, and an enhanced focus on accelerating research outcomes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp
Which Strategic Drivers Are Supporting The Artificial Intelligence In Life Sciences Market Development?
A growing focus on real-time remote patient monitoring (RPM) systems is anticipated to drive the expansion of artificial intelligence in the life sciences market in the future. Such a system represents a technologically advanced healthcare approach aimed at tracking patient well-being beyond conventional medical environments. Artificial intelligence in life sciences plays a crucial role in remote patient monitoring by delivering ongoing, tailored, and insight-driven information, which facilitates proactive healthcare strategies. For example, in April 2025, the Peterson Center on Healthcare, a US-based non-profit organization, documented that expenditures for remote therapeutic monitoring (RTM) within Traditional Medicare increased significantly, from $2.2 million in 2022 to $10.4 million in 2023. Additionally, in 2023, remote patient monitoring (RPM) services were utilized by 451,000 patients covered by Traditional Medicare. Consequently, the rising adoption of real-time remote patient monitoring (RPM) systems is fueling the expansion of artificial intelligence in the life sciences market.
How Are Different Segment Groups Identified Within The Artificial Intelligence In Life Sciences Market?
The artificial intelligence in life sciences market covered in this report is segmented –
1) By Offering: Software, Hardware, Services
2) By Deployment: On-Premises, Cloud-Based
3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision And Personalized Medicine, Patient Monitoring
Subsegments:
1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)
2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies
3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services
Which Trends Are Supporting The Evolution Of The Artificial Intelligence In Life Sciences Market?
Leading companies in the artificial intelligence in the life sciences market are concentrating on advanced products, such as drug discovery software, to maintain their market standing. Drug discovery software represents a group of computer programs and applications developed to support pharmaceutical and biotechnology researchers in identifying new medications. For example, in December 2023, Merck, a Germany-based science and technology company, introduced AIDDISON, an innovative drug discovery software. Being the first of its kind, it integrates virtual molecule design with real-world manufacturability, utilizing generative AI, machine learning, and computer-aided drug design. AIDDISON effectively pinpoints drug candidates from extensive possibilities, taking into account essential properties like non-toxicity and solubility. This capability to bridge the divide between virtual molecule design and real-world manufacturability highlights a significant application of artificial intelligence in the life sciences industry.
Which Companies Are Engaged In The Artificial Intelligence In Life Sciences Market Environment?
Major companies operating in the artificial intelligence in life sciences market are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.
Access The Complete Artificial Intelligence In Life Sciences Market Report:
Which Region Stands As The Largest Contributor To The Artificial Intelligence In Life Sciences Market?
North America was the largest region in the Artificial Intelligence In Life Sciences market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Artificial Intelligence In Life Sciences Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=13587&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence In Life Sciences Market 2026, By The Business Research Company
Ai In Life Science Analytics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-life-science-analytics-global-market-report
Artificial Intelligence In Medicine Global Market Report 2026
Life Science Analytics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/life-science-analytics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
